Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Revenue

Avalo Therapeutics had revenue of $249.00K in the quarter ending September 30, 2024, with 5.51% growth. This brings the company's revenue in the last twelve months to $820.00K, down -63.54% year-over-year. In the year 2023, Avalo Therapeutics had annual revenue of $1.92M, down -89.34%.

• Revenue (ttm): $820.00K
• Revenue Growth: -63.54%
• P/S Ratio: 25.57
• Revenue / Employee: $43,158
• Employees: 19
• Market Cap: 106.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.92M	-16.13M	-89.34%
Dec 31, 2022	18.05M	12.65M	234.40%
Dec 31, 2021	5.40M	-1.30M	-19.42%
Dec 31, 2020	6.70M	-51.35K	-0.76%
Dec 31, 2019	6.75M	-278.03K	-3.96%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.